Does EVEROLIMUS Cause Hepatic lesion? 171 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Hepatic lesion have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.4% of all adverse event reports for EVEROLIMUS.
171
Reports of Hepatic lesion with EVEROLIMUS
0.4%
of all EVEROLIMUS reports
26
Deaths
41
Hospitalizations
How Dangerous Is Hepatic lesion From EVEROLIMUS?
Of the 171 reports, 26 (15.2%) resulted in death, 41 (24.0%) required hospitalization, and 4 (2.3%) were considered life-threatening.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 171 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
ZOLEDRONIC ACID (97)
Which EVEROLIMUS Alternatives Have Lower Hepatic lesion Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE